NeuroKaire
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- $10M
Investors
- 4
About NeuroKaire
NeuroKaire, founded in 2017 in Tel Aviv, Israel, specializes in precision medicine focused on CNS diseases.NeuroKaire specializes in precision medicine for central nervous system (CNS) diseases, leveraging Nobel-Prize winning technology to develop innovative solutions. The company's core offerings include advanced, AI-enabled tests and services that utilize patient-derived induced pluripotent stem cells (iPSCs) to create neurons for personalized treatment strategies. This process begins with a simple blood sample collection, which is converted into neuronal subtypes reflective of the patient's unique neurobiology.NeuroKaire's revenue model is based on providing specialized tests and services to healthcare providers and biopharma companies. The company fosters partnerships that advance treatment optimization and drug development through direct engagements with healthcare institutions and pharmaceutical developers. Revenue is generated from service agreements, which may involve fees for the use of proprietary technology and data analysis services, along with potential subscription models for ongoing access to its comprehensive biobank and data repository. The company plans to deepen research and development and grow its network of pharmaceutical partnerships to advance precision medicine in mental health.
Who invested in NeuroKaire
4 investors across 1 round
See all investors in NeuroKaire
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 30, 2021
Amount
$10M
Investors
Questions about NeuroKaire
Who invested in NeuroKaire?
NeuroKaire has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NeuroKaire raised?
NeuroKaire has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NeuroKaire last raise money?
NeuroKaire's most recent round on record is a Series A, in Sep 2021.
What does NeuroKaire do?
NeuroKaire, founded in 2017 in Tel Aviv, Israel, specializes in precision medicine focused on CNS diseases.
Where is NeuroKaire headquartered?
NeuroKaire is headquartered in Tel Aviv, Israel.
Which VCs invest in companies like NeuroKaire?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at NeuroKaire's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like NeuroKaire? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.